Acute Pain Management Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511242842

Publication Date:

November 28, 2024

Pages:

115

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The Acute Pain Service provides care for patients requiring specialised techniques of analgesia, such as Patient Controlled Analgesia (PCA, Opioid Infusions, Epidural Analgesia, and Spinal Analgesia) for acute pain relief on an inpatient basis.
The global market for Acute Pain Management Services was estimated to be worth US$ 801 million in 2023 and is forecast to a readjusted size of US$ 975.2 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Acute Pain Management Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acute Pain Management Services by region & country, by Type, and by Application.
The Acute Pain Management Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Pain Management Services.
麻豆原创 Segmentation
By Company
Johnson & Johnson
Eli Lilly
Pfizer
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Baxter International Inc.
Purdue Pharma
Endo Pharmaceuticals Plc.
Forest Laboratories Inc.
GlaxoSmithKline Plc.
Segment by Type:
Cancer Pain
Arthritic Pain
Neuropathic Pain
Others
Segment by Application
Hospital
Clinic
麻豆原创-use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Acute Pain Management Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Acute Pain Management Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Acute Pain Management Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Acute Pain Management Services Product Introduction
1.2 Global Acute Pain Management Services 麻豆原创 Size Forecast
1.3 Acute Pain Management Services 麻豆原创 Trends & Drivers
1.3.1 Acute Pain Management Services Industry Trends
1.3.2 Acute Pain Management Services 麻豆原创 Drivers & Opportunity
1.3.3 Acute Pain Management Services 麻豆原创 Challenges
1.3.4 Acute Pain Management Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Acute Pain Management Services Players Revenue Ranking (2023)
2.2 Global Acute Pain Management Services Revenue by Company (2019-2024)
2.3 Key Companies Acute Pain Management Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Acute Pain Management Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Acute Pain Management Services
2.6 Acute Pain Management Services 麻豆原创 Competitive Analysis
2.6.1 Acute Pain Management Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Acute Pain Management Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Pain Management Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cancer Pain
3.1.2 Arthritic Pain
3.1.3 Neuropathic Pain
3.1.4 Others
3.2 Global Acute Pain Management Services Sales Value by Type
3.2.1 Global Acute Pain Management Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Acute Pain Management Services Sales Value, by Type (2019-2030)
3.2.3 Global Acute Pain Management Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 麻豆原创-use
4.2 Global Acute Pain Management Services Sales Value by Application
4.2.1 Global Acute Pain Management Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Acute Pain Management Services Sales Value, by Application (2019-2030)
4.2.3 Global Acute Pain Management Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Acute Pain Management Services Sales Value by Region
5.1.1 Global Acute Pain Management Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Acute Pain Management Services Sales Value by Region (2019-2024)
5.1.3 Global Acute Pain Management Services Sales Value by Region (2025-2030)
5.1.4 Global Acute Pain Management Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Acute Pain Management Services Sales Value, 2019-2030
5.2.2 North America Acute Pain Management Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Acute Pain Management Services Sales Value, 2019-2030
5.3.2 Europe Acute Pain Management Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Acute Pain Management Services Sales Value, 2019-2030
5.4.2 Asia Pacific Acute Pain Management Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Acute Pain Management Services Sales Value, 2019-2030
5.5.2 South America Acute Pain Management Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Acute Pain Management Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Acute Pain Management Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Acute Pain Management Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Acute Pain Management Services Sales Value
6.3 United States
6.3.1 United States Acute Pain Management Services Sales Value, 2019-2030
6.3.2 United States Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Acute Pain Management Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Acute Pain Management Services Sales Value, 2019-2030
6.4.2 Europe Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Acute Pain Management Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Acute Pain Management Services Sales Value, 2019-2030
6.5.2 China Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Acute Pain Management Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Acute Pain Management Services Sales Value, 2019-2030
6.6.2 Japan Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Acute Pain Management Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Acute Pain Management Services Sales Value, 2019-2030
6.7.2 South Korea Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Acute Pain Management Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Acute Pain Management Services Sales Value, 2019-2030
6.8.2 Southeast Asia Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Acute Pain Management Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Acute Pain Management Services Sales Value, 2019-2030
6.9.2 India Acute Pain Management Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Acute Pain Management Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Profile
7.1.2 Johnson & Johnson Main Business
7.1.3 Johnson & Johnson Acute Pain Management Services Products, Services and Solutions
7.1.4 Johnson & Johnson Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.1.5 Johnson & Johnson Recent Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Profile
7.2.2 Eli Lilly Main Business
7.2.3 Eli Lilly Acute Pain Management Services Products, Services and Solutions
7.2.4 Eli Lilly Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.2.5 Eli Lilly Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Acute Pain Management Services Products, Services and Solutions
7.3.4 Pfizer Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Teva Pharmaceutical Industries Ltd. Profile
7.4.2 Teva Pharmaceutical Industries Ltd. Main Business
7.4.3 Teva Pharmaceutical Industries Ltd. Acute Pain Management Services Products, Services and Solutions
7.4.4 Teva Pharmaceutical Industries Ltd. Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Profile
7.5.2 F. Hoffmann-La Roche Ltd. Main Business
7.5.3 F. Hoffmann-La Roche Ltd. Acute Pain Management Services Products, Services and Solutions
7.5.4 F. Hoffmann-La Roche Ltd. Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
7.6 Baxter International Inc.
7.6.1 Baxter International Inc. Profile
7.6.2 Baxter International Inc. Main Business
7.6.3 Baxter International Inc. Acute Pain Management Services Products, Services and Solutions
7.6.4 Baxter International Inc. Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.6.5 Baxter International Inc. Recent Developments
7.7 Purdue Pharma
7.7.1 Purdue Pharma Profile
7.7.2 Purdue Pharma Main Business
7.7.3 Purdue Pharma Acute Pain Management Services Products, Services and Solutions
7.7.4 Purdue Pharma Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.7.5 Purdue Pharma Recent Developments
7.8 Endo Pharmaceuticals Plc.
7.8.1 Endo Pharmaceuticals Plc. Profile
7.8.2 Endo Pharmaceuticals Plc. Main Business
7.8.3 Endo Pharmaceuticals Plc. Acute Pain Management Services Products, Services and Solutions
7.8.4 Endo Pharmaceuticals Plc. Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.8.5 Endo Pharmaceuticals Plc. Recent Developments
7.9 Forest Laboratories Inc.
7.9.1 Forest Laboratories Inc. Profile
7.9.2 Forest Laboratories Inc. Main Business
7.9.3 Forest Laboratories Inc. Acute Pain Management Services Products, Services and Solutions
7.9.4 Forest Laboratories Inc. Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.9.5 Forest Laboratories Inc. Recent Developments
7.10 GlaxoSmithKline Plc.
7.10.1 GlaxoSmithKline Plc. Profile
7.10.2 GlaxoSmithKline Plc. Main Business
7.10.3 GlaxoSmithKline Plc. Acute Pain Management Services Products, Services and Solutions
7.10.4 GlaxoSmithKline Plc. Acute Pain Management Services Revenue (US$ Million) & (2019-2024)
7.10.5 GlaxoSmithKline Plc. Recent Developments
8 Industry Chain Analysis
8.1 Acute Pain Management Services Industrial Chain
8.2 Acute Pain Management Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Acute Pain Management Services Sales Model
8.5.2 Sales Channel
8.5.3 Acute Pain Management Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Johnson & Johnson
Eli Lilly
Pfizer
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Baxter International Inc.
Purdue Pharma
Endo Pharmaceuticals Plc.
Forest Laboratories Inc.
GlaxoSmithKline Plc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.